Public list Pharma Startups (4732):
Anelixis Therapeutics was formed in 2013 and is a for-profit subsidiary of ALS Therapy Development Institute (ALSTDI), a nonprofit biotechnology organization dedicated to developing effective treatments for ALS.
Company (Alive / Active)
300 Technology Square
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)